Skip to main content

Table 3 Cumulative Incidence of CKD4 + by Start age group

From: Lifetime risk of severe kidney disease in lithium-treated patients: a retrospective study

 

Estimate % (SD%)

Start age

Follow-up time (years)

 

5

10

15

20

25

30

35

0 (18–34 years)

0.0 (0.0)

0.0 (0.0)

0.0 (0.0)

0.6 (0.5)

0.6 (0.5)

4.2 (2.1)

9.6 (4.2)

1 (35–44 years)

0.0 (0.0)

0.7 (0.4)

0.9 (0.5)

3.2 (1.0)

6.5 (1.8)

11.3 (2.7)

13.3 (3.3)

2 (45–54 years)

0.0 (0.0)

0.0 (0.0)

1.5 (0.7)

3.2 (1.1)

8.8 (2.2)

14.3 (3.4)

14.3 (3.4)

3 (55–64 years)

0.0 (0.0)

1.5 (0.7)

2.9 (1.0)

7.3 (1.6)

8.8 (2.0)

10.6 (2.6)

13.9 (4.1)*

4 (65–74 years)

1.6 (0.8)

4.0 (1.3)

10.4 (2.3)

13.2 (2.8)

18.6 (4.0)*

  

5 (≥ 75 years)

1.0 (1.0)

5.4 (2.4)

5.4 (2.4)*

    

All ages

0.2 (0.1)

1.1 (0.2)

2.4 (0.4)

4.5 (0.6)

7.2 (0.8)

10.9 (1.3)

13.2 (1.7)

  1. SD = Standard Deviation of the estimate; * Cumulative incidence equals lifetime risk for a lifetime horizon of 90 years